TW200731989A - Use of a compound comprising a camptothecin derivative for preparing pharmaceutical formulations useful in the treatment of melanoma - Google Patents

Use of a compound comprising a camptothecin derivative for preparing pharmaceutical formulations useful in the treatment of melanoma

Info

Publication number
TW200731989A
TW200731989A TW095144607A TW95144607A TW200731989A TW 200731989 A TW200731989 A TW 200731989A TW 095144607 A TW095144607 A TW 095144607A TW 95144607 A TW95144607 A TW 95144607A TW 200731989 A TW200731989 A TW 200731989A
Authority
TW
Taiwan
Prior art keywords
melanoma
treatment
pharmaceutical formulations
compound
preparing pharmaceutical
Prior art date
Application number
TW095144607A
Other languages
Chinese (zh)
Inventor
Monica Binaschi
Mario Bigioni
Original Assignee
Menarini Int Operations Lu Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Int Operations Lu Sa filed Critical Menarini Int Operations Lu Sa
Publication of TW200731989A publication Critical patent/TW200731989A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The use of a known compound of formula (I) is described, for preparing pharmaceutical formulations useful in the treatment of melanoma.
TW095144607A 2005-12-02 2006-12-01 Use of a compound comprising a camptothecin derivative for preparing pharmaceutical formulations useful in the treatment of melanoma TW200731989A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000246A ITFI20050246A1 (en) 2005-12-02 2005-12-02 USE OF A COMPOSITE INCLUDING A CAMPTOTECIN DERIVATIVE FOR THE PREPARATION OF USEFUL PHARMACEUTICAL FORMULATIONS IN THE TREATMENT OF MELANOMA

Publications (1)

Publication Number Publication Date
TW200731989A true TW200731989A (en) 2007-09-01

Family

ID=37771061

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095144607A TW200731989A (en) 2005-12-02 2006-12-01 Use of a compound comprising a camptothecin derivative for preparing pharmaceutical formulations useful in the treatment of melanoma

Country Status (4)

Country Link
AR (1) AR057958A1 (en)
IT (1) ITFI20050246A1 (en)
TW (1) TW200731989A (en)
WO (1) WO2007063124A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG50747A1 (en) * 1995-08-02 1998-07-20 Tanabe Seiyaku Co Comptothecin derivatives

Also Published As

Publication number Publication date
ITFI20050246A1 (en) 2007-06-03
AR057958A1 (en) 2007-12-26
WO2007063124A1 (en) 2007-06-07

Similar Documents

Publication Publication Date Title
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
HK1125358A1 (en) Substituted cyclohexylmethyl derivatives
MX2009006742A (en) Novel compounds.
IL204437A (en) Cyclopropyl aryl amide derivatives and uses thereof
IL185611A0 (en) Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
GEP20115231B (en) 2-amino-7,8-dihydro-6h-pyrido [4,3-d] pyrimidin-5-ones
MX2010003156A (en) Tetrazole-substituted aryl amide derivatives and uses thereof.
TW200626553A (en) Novel compounds
MX2010009022A (en) 16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use.
MY153921A (en) Aminopyrazole derivatives
PL1758852T3 (en) Substituted cyclopentene compounds
TW200639156A (en) New compounds
WO2005021544A3 (en) N3-substituted imidazopyridine-derivatives as c-kit inhibitors
SE0401762D0 (en) Novel compounds
JO2682B1 (en) 7-ALkynyl-1,8-Naphthyridone Derivatives, Preparation Thereof And Therapeutic Use Thereof
HK1114516A1 (en) Substituted sulfoxide compounds, methods for preparing the same and use thereof
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
TW200626581A (en) Compounds, compositions containing them, preparation thereof and uses thereof
TW200738697A (en) Benzimidazole derivatives as 5-HT6,5-HT24
MXPA05010020A (en) Oxamide derivatives useful as raf-kinase inhibitors.
PA8646301A1 (en) INHIBITORS OF THE SOLUBLE CYCLING ADENYLATE
MX2007008585A (en) Peptidic compounds.
MX2009005912A (en) Heterocyclyl-substituted-ehylamino-phenyl derivatives, their preparation and use as medicaments.
MY150428A (en) Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same
TNSN08242A1 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof